About Nikom Pharma Marketing
Nikom Pharma Marketing is a company based in Mumbai (India) founded in 2003. It operates as a B2B. Nikom Pharma Marketing operates in a competitive market with competitors including OPEN Health, Target RWE, Secura Bio, STATinMED Research and Abacus Medicine, among others.
- Headquarter Mumbai, India
- SectorsHealthcare
- Website nikomgroup.in
- Legal Name Nikom Pharmaceutical Private Limited
- Date of Incorporation 04 Jul, 2003
- Jurisdiction Mumbai, Maharashtra, India
- Net Loss-₹1.65 Cr
FY 2022 · 0% margin
- EBITDA-₹1.46 Cr
FY 2022 · 0% margin
Associated legal entities of Nikom Pharma Marketing
Nikom Pharma Marketing operates through Nikom Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nikom Pharmaceutical Private Limited CIN U24230MH2003PTC141173 | Active | 04 Jul 2003 | Mumbai, Maharashtra | – | – | 3 | View details |
Board of directors of Nikom Pharmaceutical Private Limited (Nikom Pharma Marketing)
Nikom Pharmaceutical Private Limited is the primary company behind Nikom Pharma Marketing. The board of Nikom Pharmaceutical Private Limited currently have 3 directors; the longest-serving is Akella Subrahmanyam, appointed in 2015. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Akella Subrahmanyam DIN 03629021 | Director | 25 Jun 2015 | 11 yrs 3 mo | Nikom Pharmaceutical Private Limited |
| Anagha Rajesh Pathak DIN 07928446 | Additional Director | 17 Jul 2021 | 5 yrs 2 mo | Nikom Pharmaceutical Private Limited |
| Hetal Mohan Parmar DIN 09169559 | Director | 04 Jul 2025 | 1 yr 3 mo | Nikom Pharmaceutical Private Limited |
Financials of Nikom Pharma Marketing
Figures of Nikom Pharmaceutical Private Limited, the primary company behind Nikom Pharma Marketing, for FY 2022. Net loss was -₹1.65 Cr (0% margin). EBITDA was -₹1.46 Cr (0% margin). Revenue has grown at a compounded annual rate of -100% over three years and -100% over five years.
- -₹1.65 CrNet loss · 0% margin
- -₹1.46 CrEBITDA · 0% margin
- ₹21 LakhPaid-up capital
- -100%Revenue CAGR, 3 years
- -100%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nikom Pharmaceutical Private Limited are on its company page.
Detailed financial statements for Nikom Pharma Marketing
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Nikom Pharma Marketing
Nikom Pharma Marketing operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OPEN Health, Target RWE, Secura Bio, STATinMED Research and Abacus Medicine, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| openhealthgroup.com | 2016 | Marlow, United Kingdom | $5.28M | 297 | Provider of healthcare marketing services | |
| targetrwe.com | 2017 | Durham, United States | – | 116 | Marketing services to the pharmaceutical industry are provided. | |
| securabio.com | 2018 | Henderson, United States | $55M | – | Consulting services for market access and health outcomes are provided. | |
| statinmed.com | 2007 | Ann Arbor, United States | – | – | Healthcare data analytics services provider | |
| abacusmedicine.com | 2004 | Copenhagen, Denmark | $57.64M | 1,052 | Consulting services for market access, health economics and outcomes research | |
| hylant.com | 1935 | Toledo, United States | – | 849 | Offers business insurance, employee benefits, and risk consulting services worldwide. | |
| gba-group.com | 1975 | Hamburg, Germany | – | – | GBA Group is recognized as a leading life sciences service provider. | |
| huameihaolian.com | 2021 | China | – | – | Commercial services for biopharma sector are provided by Huameihaolian. |
Detailed competitors of Nikom Pharma Marketing
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Nikom Pharma Marketing
10 companies that operate in the same segment as Nikom Pharma Marketing (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nikom Pharma Marketing
Nikom Pharma Marketing was founded in 2003.
Nikom Pharma Marketing is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Nikom Pharma Marketing provides comprehensive marketing services tailored for the pharmaceutical industry through providing healthcare solutions, producing pharmaceutical products, marketing services, and pharma promotion. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Nikom Pharma Marketing's top competitors include OPEN Health, Abacus Medicine and Target RWE.
Nikom Pharma Marketing operates through Nikom Pharmaceutical Private Limited.
The legal entities of Nikom Pharma Marketing currently have 3 directors, including Hetal Mohan Parmar, Anagha Rajesh Pathak, Akella Subrahmanyam.